Figure 1.
(a) Correlation between changes in HbA1c after 6-month sitagliptin treatment and HbA1c levels at baseline. (b) Correlation between changes in HbA1c after 6-month sitagliptin treatment and daily glucocorticoids dose at baseline.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.